Skip to content

Cryoport

US · CYRX #3336 by market cap Listed 2015
19.05 -0.50 -2.56%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Cryoport

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Founded
1990
CEO
Mr. Jerrell W. Shelton
Employees
738
Headquarters
Brentwood, Tennessee, United States of America
Fiscal year end
12-31
Website
cryoportinc.com

Company profile

Exchange
US
Symbol
CYRX
Market-cap rank
#3336
Listing date
2015-04-23
Market cap
965.84M
Float cap
932.12M
Shares out
50.70M
Float shares
48.93M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Cryoport discussion 0 comments

Add a comment